Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
BMC Gastroenterology|April 6, 2026
Burden of metabolic dysfunction-associated steatohepatitis, with and without metabolic syndrome, obesity, or diabetesElliot B Tapper, Taylor Ryan, Dave Lewandowski, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 28, 2025
Retrospective Study of Real-World Treatment Patterns of Subcutaneous Semaglutide Use Among Patients with Metabolic Dysfunction-Associated Steatohepatitis in the United StatesYestle Kim, Ni Zeng, Jessamine P Winer-Jones, et al.
Journal of Comparative Effectiveness Research|October 6, 2025
Healthcare costs and treatment patterns associated with glucagon-like peptide 1 receptor agonist use among patients with metabolic dysfunction-associated steatohepatitisElliot B Tapper, Taylor Ryan, Ni Zeng, et al.
BMC Endocrine Disorders|May 1, 2024
Obesity and metabolic syndrome in patients with heart failure with preserved ejection fraction: a cross-sectional analysis of the Veradigm Cardiology RegistryJay P Bae, Lee Kallenbach, David R Nelson, et al.
Journal of Health Care for the Poor and Underserved|December 19, 2022
Federated Electronic Health Record Database via a Public-Private Partnership to Enhance Health Care Equity by Disparity Discovery and Equitable Clinical Trial RecruitmentZachary D Urdang, Isatu M Kargbo, Emily E Noss, et al.
Diseases (Basel, Switzerland)|January 22, 2024
Comparison of COVID-19 and Influenza-Related Outcomes in the United States during Fall-Winter 2022-2023: A Cross-Sectional Retrospective StudyHagit Kopel, Alina Bogdanov, Jessamine P Winer-Jones, et al.
JAMIA Open|May 16, 2023
A global federated real-world data and analytics platform for researchMatvey B Palchuk, Jack W London, David Perez-Rey, et al.
Journal of Medical Economics|August 19, 2025
Economic burden of growth hormone deficiency among adults who are at risk for and who have confirmed growth hormone deficiency using US real-world dataAndrew R Hoffman, Subhara Raveendran, Janna Manjelievskaia, et al.
Advances in Therapy|April 22, 2025
Prevalence, Treatment Patterns, and Characteristics of US Adults with Confirmed or at Risk for Growth Hormone DeficiencyAndrew R Hoffman, Subhara Raveendran, Janna Manjelievskaia, et al.
Open Forum Infectious Diseases|December 18, 2024
Effectiveness of the 2023-2024 Omicron XBB.1.5-containing mRNA COVID-19 Vaccine (mRNA-1273.815) in Preventing COVID-19-related Hospitalizations and Medical Encounters Among Adults in the United StatesHagit Kopel, Andre B Araujo, Alina Bogdanov, et al.
Pageof 2